Foresight Diagnostics Inc.

United States - Aurora, CO

• 28/04/2023
• Series B
• $58,750,000

Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) for aid in patient management that is funded by leading diagnostics VC firms in Silicon Valley. Foresight’s cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The company has garnered significant partnering interest from multiple pharmaceutical companies in oncology and is poised for rapid growth. Foresight Diagnostics is headquartered in Aurora, Colorado.

Related People

Jake ChabonCo Founder

United States - Denver, Colorado

I am molecular biologist and bioinformatic scientist with a passion for entrepreneurship. I completed my graduate and postdoctoral training at Stanford University where my research was focused on developing novel blood based cancer diagnostic assays. I am now the CEO & Co-founder of Foresight Diagnostics, a venture-backed molecular diagnostics company that is developing non-invasive cancer detection technologies. Foresight’s unique cell-free DNA testing platform enables the ultra-sensitive detection of tumor-derived DNA in the bloodstream, leading to more personalized and effective cancer treatment strategies for patients.

LinkedIn https://www.linkedin.com/in/jake-chabon-b1874414/